Concepedia
Statistics
Publications
7
Citations
409
H-Index
Active since
2021
Affiliations
Merck (Germany)(Current)
AstraZeneca (United Kingdom)
Merck & Co., Inc., Rahway, NJ, USA (United States)
United States Pharmacopeial Convention
Joerg Schlingemann is an author at Merck (Germany) specializing in drug discovery, drug development, and drug analysis.
Top concepts
MedicinePharmacologyDrug AnalysisDrug DiscoveryDrug DevelopmentMedicinal ChemistryToxicologyBiochemistryNatural SciencesBioanalysis
Publications per year
2021–2023
The Landscape of Potential Small and Drug Substance Related Nitrosamines in Pharmaceuticals
Joerg Schlingemann, Michael J. Burns, David J. Ponting et al. · Journal of Pharmaceutical Sciences · 2022 · 115 citations · Full text
A Nitrite Excipient Database: A Useful Tool to Support N-Nitrosamine Risk Assessments for Drug Products
Ruth Boetzel, Joerg Schlingemann, Sebastian Hickert et al. · Journal of Pharmaceutical Sciences · 2022 · 83 citations
Drug Safety, Medicinal Chemistry, Predictive Toxicology +13
The Nitrosamine “Saga”: Lessons Learned from Five Years of Scrutiny
Raphael Nudelman, Grace Kocks, Bruno Mouton et al. · Organic Process Research & Development · 2023 · 68 citations · Full text
Pharmaceutical Science, Na Exposure, Nitrosative Stress +17
Avoiding N-nitrosodimethylamine formation in metformin pharmaceuticals by limiting dimethylamine and nitrite
Joerg Schlingemann, Céline Boucley, Sebastian Hickert et al. · International Journal of Pharmaceutics · 2022 · 60 citations · Full text
Pharmaceutical Science, Methanol, Organic Chemistry +20
NDMA analytics in metformin products: Comparison of methods and pitfalls
Matthias Fritzsche, Giorgio Blom, Judith Keitel et al. · European Journal of Pharmaceutical Sciences · 2021 · 41 citations · Full text
1–5 of 7